BIOLIFE4D is an emerging biotech company focused on leveraging advances in life sciences, bioengineering, and to 3D bioprint viable human cardiac components. The Company introduced the first mini-heart to the market in 2019 which we expects to become the “Gold Standard” used in pharmaceutical screening & research. We continues to work towards its ultimate objective of creating a bioengineered complete human heart suitable for transplantation.